Apyx Medical Corporation (FRA:BOV)
Germany · Delayed Price · Currency is EUR 3.400
0.00 (0.00%)
At close: Nov 28, 2025
Apyx Medical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -14.54 | -23.46 | -18.71 | -23.18 | -15.17 | -11.9 | Upgrade |
Depreciation & Amortization | 0.58 | 0.6 | 0.69 | 0.89 | 0.9 | 0.89 | Upgrade |
Loss (Gain) From Sale of Assets | -0.02 | 0.01 | -2.53 | 0.08 | 0.05 | 0.01 | Upgrade |
Stock-Based Compensation | 2.34 | 4.01 | 5.11 | 6.7 | 5.09 | 4.21 | Upgrade |
Provision & Write-off of Bad Debts | 0.54 | 0.4 | 0.28 | 0.32 | 0.13 | 0.26 | Upgrade |
Other Operating Activities | 1.92 | 1.64 | 4.37 | 0.14 | 0.4 | 0.71 | Upgrade |
Change in Accounts Receivable | -0.34 | -2.04 | -3.57 | 1.92 | -4.9 | -0.56 | Upgrade |
Change in Inventory | -0.22 | 2.26 | 1.46 | -5.57 | -2.86 | 0.62 | Upgrade |
Change in Accounts Payable | 1.27 | -0.06 | 0.03 | 0.07 | 1.15 | -0.97 | Upgrade |
Change in Income Taxes | - | - | 7.55 | 0.1 | 0.01 | -7.23 | Upgrade |
Change in Other Net Operating Assets | 0.07 | -1.41 | 0.09 | -1.73 | 4.75 | -2.12 | Upgrade |
Operating Cash Flow | -8.41 | -18.05 | -5.25 | -20.28 | -10.45 | -16.07 | Upgrade |
Capital Expenditures | -1.08 | -0.72 | -0.53 | -1.01 | -0.72 | -0.58 | Upgrade |
Sale of Property, Plant & Equipment | - | - | 7.27 | - | - | - | Upgrade |
Investing Cash Flow | -1.08 | -0.72 | 6.73 | -1.01 | -0.72 | -0.58 | Upgrade |
Long-Term Debt Issued | - | - | 43.47 | - | - | - | Upgrade |
Short-Term Debt Repaid | - | - | - | - | - | -0.14 | Upgrade |
Long-Term Debt Repaid | - | -0.02 | -11.07 | -0.15 | -0.24 | -0.23 | Upgrade |
Total Debt Repaid | -0.02 | -0.02 | -11.07 | -0.15 | -0.24 | -0.37 | Upgrade |
Net Debt Issued (Repaid) | -0.02 | -0.02 | 32.41 | -0.15 | -0.24 | -0.37 | Upgrade |
Issuance of Common Stock | 7.05 | 7 | 0.09 | 0.37 | 0.07 | 0.15 | Upgrade |
Other Financing Activities | -0.18 | -0.24 | -0.33 | - | 0.2 | 0.15 | Upgrade |
Financing Cash Flow | 6.86 | 6.75 | 32.17 | 0.22 | 0.02 | -0.07 | Upgrade |
Foreign Exchange Rate Adjustments | -0.24 | 0.11 | -0.19 | 0.4 | 0.1 | -0.18 | Upgrade |
Net Cash Flow | -2.88 | -11.91 | 33.46 | -20.68 | -11.05 | -16.9 | Upgrade |
Free Cash Flow | -9.49 | -18.77 | -5.78 | -21.29 | -11.17 | -16.65 | Upgrade |
Free Cash Flow Margin | -19.81% | -39.02% | -11.04% | -47.83% | -23.03% | -60.07% | Upgrade |
Free Cash Flow Per Share | -0.24 | -0.53 | -0.17 | -0.62 | -0.33 | -0.49 | Upgrade |
Cash Interest Paid | 4.64 | 4.75 | 1.94 | 0.02 | 0.01 | 0.05 | Upgrade |
Cash Income Tax Paid | 0.25 | 0.38 | 0.33 | 0.13 | 0.11 | 0.08 | Upgrade |
Levered Free Cash Flow | -5.91 | -11.58 | -1.9 | -5.54 | -5.33 | -17.36 | Upgrade |
Unlevered Free Cash Flow | -2.26 | -7.88 | -0.35 | -5.53 | -5.33 | -17.33 | Upgrade |
Change in Working Capital | 0.77 | -1.25 | 5.54 | -5.22 | -1.84 | -10.25 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.